Bedside To Bench: New Pathways For Understanding IBD
Dr. Aida Habtezion and Stanford University make promising advances through technology and collaboration.
Researchers
Below are researchers funded by the Kenneth Rainin Foundation who are working in immunity and inflammation.
Dan Littman, MD, Ph
Professor, New York University Grossman School of Medicine, Current Grantee
Dr. Littman’s lab studies how information from the environment, including microbiota and metabolites, is relayed to cells of the immune system and how this is manifested in homeostatic processes as well as in pathological conditions.
Carrie Lucas, PhD
Associate Professor, Yale University, Former Grantee
The Lucas lab strives to discover mechanisms of disease driving rare immune disorders, focusing on the genetic, cellular and biochemical underpinnings that can illuminate fundamental biology and broadly inform diagnoses and treatments.
Susan Lynch, PhD
Professor; University of California, San Francisco; Former Grantee
The Lynch lab focuses primarily on the human microbiota in both respiratory and gastrointestinal tracts, environmental microbial exposures that shape its development and its role in chronic inflammatory diseases.
Ankit Malik, PhD
Assistant Professor, University of North Carolina at Chapel Hill, Current Grantee
Dr. Malik work focuses on how the immune system at mucosal surfaces reacts to pathogens, commensals, and environmental agents, and how that affects local and distal diseases.
Eric Martens, PhD
Professor, University of Michigan, Former Grantee
The Martens lab investigates the symbiotic microorganisms in the human gastrointestinal tract at multiple levels with the goal of using diet and gut microbial interventions to treat chronic conditions such as Inflammatory Bowel Disease.
Markus Neurath, PhD
Doctor, Friedrich-Alexander-Universität Erlangen-Nürnberg, Former Grantee
Dr. Neurath studies the immunologic and molecular mechanisms in the pathogenesis of Inflammatory Bowel Disease and gastrointestinal cancer to create new therapeutic options for patients.
